Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized studyDenise Hilfiker‐Kleiner, Johann Bauersachs, Dominik Berliner et al.|European Heart Journal|2017Cited by 334
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trialStefan Hagel, Hicham Chkirni, Stefan Kluge et al.|Intensive Care Medicine|2022Cited by 171
Recommendations for extracorporeal cardiopulmonary resuscitation (eCPR): consensus statement of DGIIN, DGK, DGTHG, DGfK, DGNI, DGAI, DIVI and GRCGuido Michels, Hölger Thiele, Tobias Wengenmayer et al.|Clinical Research in Cardiology|2018Cited by 120
Long-Term Follow-up in Peripartum Cardiomyopathy Patients with Contemporary Treatment: Low Mortality, High Cardiac Recovery, but Significant Cardiovascular Co-MorbiditiesValeska Abou Moulig, Johann Bauersachs, Tobias J. Pfeffer et al.|European Journal of Heart Failure|2019Cited by 81
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunctionJohann Bauersachs, Johannes Schwab, Jens Vogel‐Claussen et al.|Clinical Research in Cardiology|2018Cited by 41